VIENNA, VA (August 20, 2020) – Many healthcare professionals are giving more attention to Aspirin-Exacerbated Respiratory Disease (AERD), a chronic medical condition that involves asthma, persistent nasal polyps and a sensitivity to aspirin or other non-steroidal anti-inflammatory drugs (NSAID).
As part of raising awareness of AERD, Allergy & Asthma Network and the Samter’s Society announce that AERD Awareness Day this year is Saturday, Sept. 26, 2020.
The theme for AERD Awareness Day is “Moving Forward with AERD.” Allergy & Asthma Network and the Samter’s Society will distribute educational resources in print and online about the condition, which affects approximately 1.2 million to 1.6 million people in the United States. AERD, also known as Samter’s Triad, develops in adulthood, usually between the ages of 20 and 50.
AERD Awareness Day highlights the many concerns facing people with AERD, including disease severity, prevention strategies and treatment options such as aspirin desensitization.
AERD is a very complex disease – symptoms do not often respond to conventional treatments and many patients also experience chronic sinus infections and a loss of sense of smell. The goal of the awareness day is to encourage doctors and patients to stay vigilant in recognizing, understanding and managing the condition, especially during the COVID-19 pandemic.
AERD Awareness Day began in 2018 with a fundraiser to promote clinical research of the disease as well as distribute patient education materials and poster displays for allergists, asthma educators, respiratory therapists and other medical professionals.
For more on AERD Awareness Day, visit these valuable web resources:
Please consider donating to the AERD research fundraiser as well!